Evidence map›Paper›PMID 41332909›Full record

ArticleBiochemistry and biophysics reports2025

Integration of single-cell and RNA-seq analysis reveals sepsis heterogeneity and prognostic significance of FCGR3A+ Macrophage subtypes.

Yijia He, Shuanghu Dong, Lifen Ouyang, Jun Kang, Liying Chen, Qingyun He

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yijia HeThe First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, China.
Shuanghu DongDepartment of Intensive Care Unit, Jiangxi Province Hospital of Integrated Traditional Chinese and Western Medicine, 330003, China.
Lifen OuyangDepartment of Intensive Care Unit, Jiangxi Province Hospital of Integrated Traditional Chinese and Western Medicine, 330003, China.
Jun KangAffiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, 330006, China.
Liying ChenDepartment of Intensive Care Unit, Jiangxi Province Hospital of Integrated Traditional Chinese and Western Medicine, 330003, China.
Qingyun HeDepartment of Intensive Care Unit, Jiangxi Province Hospital of Integrated Traditional Chinese and Western Medicine, 330003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis, a pressing global health challenge, is characterized by immune dysregulation and high mortality. This study, in response to this urgent need, integrated Single-cell RNA sequencing data from 53 samples and bulk transcriptomic data from 479 sepsis patients to analyze immune microenvironment heterogeneity and develop a prognostic signature. Using the scVI algorithm, eight immune cell types were identified. B, T, and NK cells were reduced in sepsis, while neutrophils were elevated. "BayesPrism" analysis linked higher macrophage abundance to improved survival. A pro-inflammatory FCGR3A + macrophage (Macro_1_FCGR3A) subset exhibited high M1 scores, enhanced antigen presentation, and activation of the PI3K-AKT-mTOR and TNF-NFκB pathways. Pseudotime analysis showed terminal differentiation with elevated HLA-DRB1 and CXCL10. A prognostic model using "StepCox + Ridge" selected 13 key genes, including CX3CR1, achieving AUCs (Area Under the Curve) of 0.77 (training) and 0.69 (validation). CX3CR1 showed strong diagnostic potential (AUC = 0.982). These findings reveal the pivotal role of FCGR3A + macrophages in sepsis prognosis.

Indexed as

FCGR3AImmunologyMacrophage subtypesSepsisSingle cell and RNA-Seq

Identifiers

PMID41332909
PMCPMC12666706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.